Literature DB >> 27682635

Effects of acute doses of methylphenidate on inflammation and oxidative stress in isolated hippocampus and cerebral cortex of adult rats.

Majid Motaghinejad1, Manijeh Motevalian2, Behnaz Shabab3, Sulail Fatima4.   

Abstract

Methylphenidate (MPH) is a stimulatory agent in brain with unknown long-term consequences. In this study, MPH-induced neurodegeneration in adult rat brain was assessed. Rats were acutely treated with different doses of MPH. Open Field Test was used to investigate anxiety and depression levels. Inflammatory factors and anti-oxidant activity were also evaluated in isolated hippocampus and cerebral cortex. MPH treated groups (10 and 20 mg/kg) demonstrated anxiety and depression like behavior in OFT. MPH significantly increased lipid peroxidation, GSSG level, IL-1β and TNF-α in isolated tissues. In addition, MPH at the same doses (10 and 20 mg/kg) reduced GSH, superoxide dismutase, glutathione peroxidase and glutathione reductase activity significantly in hippocampus and cerebral cortex. In conclusion, acute administration of high doses of MPH can cause oxidative and inflammatory changes in brain cells and induce neurodegeneration in hippocampus and cerebral cortex of adult rats.

Entities:  

Keywords:  Cerebral cortex; Hippocampus; Inflammation; Methylphenidate; Oxidative stress

Mesh:

Substances:

Year:  2016        PMID: 27682635     DOI: 10.1007/s00702-016-1623-5

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  51 in total

1.  Methylphenidate-elicited dopamine increases in ventral striatum are associated with long-term symptom improvement in adults with attention deficit hyperactivity disorder.

Authors:  Nora D Volkow; Gene-Jack Wang; Dardo Tomasi; Scott H Kollins; Tim L Wigal; Jeffrey H Newcorn; Frank W Telang; Joanna S Fowler; Jean Logan; Christopher T Wong; James M Swanson
Journal:  J Neurosci       Date:  2012-01-18       Impact factor: 6.167

2.  Involvement of AMPA/kainate and GABAA receptors in topiramate neuroprotective effects against methylphenidate abuse sequels involving oxidative stress and inflammation in rat isolated hippocampus.

Authors:  Majid Motaghinejad; Manijeh Motevalian
Journal:  Eur J Pharmacol       Date:  2016-04-19       Impact factor: 4.432

3.  Chronic administration of methylphenidate activates mitochondrial respiratory chain in brain of young rats.

Authors:  Ana O Fagundes; Gislaine T Rezin; Francine Zanette; Eliane Grandi; Lara C Assis; Felipe Dal-Pizzol; João Quevedo; Emilio L Streck
Journal:  Int J Dev Neurosci       Date:  2006-12-22       Impact factor: 2.457

4.  Behavioral pharmacological similarities between methylphenidate and cocaine in cocaine abusers.

Authors:  C R Rush; R W Baker
Journal:  Exp Clin Psychopharmacol       Date:  2001-02       Impact factor: 3.157

Review 5.  Acute toxic effects of 'Ecstasy' (MDMA) and related compounds: overview of pathophysiology and clinical management.

Authors:  A P Hall; J A Henry
Journal:  Br J Anaesth       Date:  2006-04-04       Impact factor: 9.166

Review 6.  A review of the pharmacotherapy of adults with attention-deficit/hyperactivity disorder.

Authors:  Timothy E Wilens; Thomas J Spencer; Joseph Biederman
Journal:  J Atten Disord       Date:  2002-03       Impact factor: 3.256

7.  Acute and sub-chronic functional neurotoxicity of methylphenidate on neural networks in vitro.

Authors:  K V Gopal; B R Miller; G W Gross
Journal:  J Neural Transm (Vienna)       Date:  2007-06-18       Impact factor: 3.575

8.  Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat.

Authors:  S Pellow; P Chopin; S E File; M Briley
Journal:  J Neurosci Methods       Date:  1985-08       Impact factor: 2.390

Review 9.  Current research on methamphetamine-induced neurotoxicity: animal models of monoamine disruption.

Authors:  Taizo Kita; George C Wagner; Toshikatsu Nakashima
Journal:  J Pharmacol Sci       Date:  2003-07       Impact factor: 3.337

10.  Protective Effects of Liposomal N-Acetylcysteine against Paraquat-Induced Cytotoxicity and Gene Expression.

Authors:  Panagiotis Mitsopoulos; Zacharias E Suntres
Journal:  J Toxicol       Date:  2011-04-04
View more
  16 in total

1.  Chronic oral methylphenidate treatment increases microglial activation in rats.

Authors:  Emily Carias; John Hamilton; Lisa S Robison; Foteini Delis; Rina Eiden; Teresa Quattrin; Michael Hadjiargyrou; David Komatsu; Panayotis K Thanos
Journal:  J Neural Transm (Vienna)       Date:  2018-09-20       Impact factor: 3.575

2.  Topiramate Confers Neuroprotection Against Methylphenidate-Induced Neurodegeneration in Dentate Gyrus and CA1 Regions of Hippocampus via CREB/BDNF Pathway in Rats.

Authors:  Majid Motaghinejad; Manijeh Motevalian; Mohammad Abdollahi; Mansour Heidari; Zahra Madjd
Journal:  Neurotox Res       Date:  2017-01-11       Impact factor: 3.911

Review 3.  The pharmacology of amphetamine and methylphenidate: Relevance to the neurobiology of attention-deficit/hyperactivity disorder and other psychiatric comorbidities.

Authors:  Stephen V Faraone
Journal:  Neurosci Biobehav Rev       Date:  2018-02-08       Impact factor: 8.989

4.  Topiramate via NMDA, AMPA/kainate, GABAA and Alpha2 receptors and by modulation of CREB/BDNF and Akt/GSK3 signaling pathway exerts neuroprotective effects against methylphenidate-induced neurotoxicity in rats.

Authors:  Majid Motaghinejad; Manijeh Motevalian; Sulail Fatima; Tabassom Beiranvand; Shiva Mozaffari
Journal:  J Neural Transm (Vienna)       Date:  2017-08-09       Impact factor: 3.575

5.  Evidence That Methylphenidate Treatment Evokes Anxiety-Like Behavior Through Glucose Hypometabolism and Disruption of the Orbitofrontal Cortex Metabolic Networks.

Authors:  Felipe Schmitz; Josiane S Silveira; Gianina T Venturin; Samuel Greggio; Guilherme Schu; Eduardo R Zimmer; Jaderson Costa Da Costa; Angela T S Wyse
Journal:  Neurotox Res       Date:  2021-11-19       Impact factor: 3.911

6.  Effect of Vitamin D on Paraxonase-1, Total Antioxidant Capacity, and 8-Isoprostan in Children with Attention Deficit Hyperactivity Disorder.

Authors:  Niyaz Mohammadzadeh Honarvar; Mahsa Samadi; Marzieh Seyedi Chimeh; Fatemeh Gholami; Niki Bahrampour; Mahmoud Jalali; Mohammad Effatpanah; Mir Saeid Yekaninejad; Mina Abdolahi; Maryam Chamari
Journal:  Int J Clin Pract       Date:  2022-01-31       Impact factor: 3.149

7.  New Hematological Parameters as Inflammatory Biomarkers: Systemic Immune Inflammation Index, Platerethritis, and Platelet Distribution Width in Patients with Adult Attention Deficit Hyperactivity Disorder.

Authors:  Hacer Akgül Ceyhun; Nilifer Gürbüzer
Journal:  Adv Neurodev Disord       Date:  2022-05-11

8.  Selegiline acts as neuroprotective agent against methamphetamine-prompted mood and cognitive related behavior and neurotoxicity in rats: Involvement of CREB/BDNF and Akt/GSK3 signal pathways.

Authors:  Saba Feizipour; Sarvenaz Sobhani; Shafagh Mehrafza; Mina Gholami; Majid Motaghinejad; Manijeh Motevalian; Sepideh Safari; Reza Davoudizadeh
Journal:  Iran J Basic Med Sci       Date:  2020-05       Impact factor: 2.699

9.  Increased Alopecia Areata Risk in Children with Attention-Deficit/Hyperactivity Disorder and the Impact of Methylphenidate Use: A Nationwide Population-Based Cohort Study.

Authors:  Hsing-Ying Ho; Chih-Kai Wong; Szu-Yuan Wu; Ray C Hsiao; Yi-Lung Chen; Cheng-Fang Yen
Journal:  Int J Environ Res Public Health       Date:  2021-02-01       Impact factor: 3.390

10.  Duloxetine by Modulating the Akt/GSK3 Signaling Pathways Has Neuroprotective Effects against Methamphetamine-Induced Neurodegeneration and Cognition Impairment in Rats.

Authors:  Mehrasa Rahimi Borumand; Majid Motaghinejad; Manijeh Motevalian; Mina Gholami
Journal:  Iran J Med Sci       Date:  2019-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.